International legal regulation of the use of artificial intelligence in the health care sector

2022

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.32523/2616-6844-2022-140-3-47-53
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The use of artificial intelligence technologies in healthcare offers truly impressive prospects. At the same time, the healthcare industry is traditionally and reasonably conservative. Many applications of technologies and products, from drugs to innovative solutions, require state control and management through legal regulation. In this article, we have listed some important regulatory legal acts (RLAs) that somehow govern the use of AI in healthcare. The article analyzes the international legal norms regarding the use of artificial intelligence in the field of health both at the international and national levels. The review examines the problems of using artificial intelligence in various fields of medicine, such as the diagnosis of diseases, recommendations for their treatment, and administrative activities in healthcare. The article analyzes prospects for the development of AI, conflicting views, and potential pitfalls in its implementation.